04.28.25
Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.
View full description +
Subscribe
10.02.25
Survey Says: Reducing Medication Burden for an Unhappy PatientI. Paul Singh, MD; Emily Schehlein, MD; and H. George Tanaka, MD
08.15.25
Sustained Drug Delivery in Interventional GlaucomaI. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD
06.26.25
Survey Says: Choosing Treatment for a High-Risk PatientI. Paul Singh, MD; Erin Sieck, MD; and Arkadiy Yadgarov, MD
05.23.25
Career Change: Making the Vision Come to Life • Private Practice Versus AcademiaZahra Ali, MD; and Devang L. Bhoiwala, MD
03.19.25
Survey Says: Proceeding After Unsuccessful TreatmentI. Paul Singh, MD; Manjool Shah, MD; and Ticiana De Francesco, MD,
Show More